IBDM is recruiting
group leaders !
We invite applications from
scientists to join us.
Tuesday 23 November 2021
We invite applications from creative early-career scientists investigating a fundamental question in developmental biology to join the IBDM community.
Tuesday 2 November 2021
Our findings provide mechanistic insight into the mechanism by which TAFA4 reverses injury-induced mechanical hypersensitivity, by restoring normal spinal neuron activity, and highlight the considerable potential of TAFA4 as a treatment for injury-induced mechanical pain.
Tuesday 26 October 2021
Through an international collaboration, using breast cancer as a biological paradigm, Flavio Maina Team publishes a work in the Theranostics journal exemplifying how specificity in targeting cell cycle regulators is essential for combinatorial cancer therapies.
Tuesday 26 October 2021
Lydia Kerkerian-Le Goff was awarded the Chevalier de la Légion d’Honneur by Geneviève Rougon on Friday 1 October at the Hexagon, Emeritus researcher at the Institute of Neurosciences at La Timone…
Wednesday 6 October 2021
Americans David Julius, born in 1955 in New York, and Ardem Patapoutian, born in 1967 in Beirut and of Lebanese-Armenian origin, were awarded the prize for their discoveries of temperature and touch receptors.
Tuesday 10 August 2021
7 IBDM teams have received grants from the Agence Nationale pour la Recherche (ANR) in 2021. Congratulations to Vincent Bertrand, Harold Cremer, Pascale Durbec, André Le Bivic, Pierre-François Lenne, Cédric Maurange and Julien Royet.
Tuesday 3 August 2021
Jules Lavalou and Qiyan Mao from Thomas Lecuit’s team report that Toll-8 controls myosin-II planar polarity in Drosophila embryos and wing discs via a physical interaction with the GPCR Cirl/latrophilin.
Thursday 17 June 2021
Antoine Barrière and Amel Toudji-Zouaz in the Bertrand team developed a new method to image and quantify transcription in vivo.
Friday 14 May 2021
This study published in Cell Death & Disease, conducted by the team of L. Kerkerian-Le Goff provides the first evidence for a role of the stress-induced protein TP53INP1 in the maintenance of neuronal homeostasis in ageing and Parkinson’s disease-related stress conditions.
Wednesday 5 May 2021
Tafalgie Therapeutics is a new start-up company created in November 2020, based on the work of Aziz Moqrich’s team “Chronic pain: cellular and molecular mechanisms” at IBDM.
- External seminar : Yad Ghavi-Helm, thursday, December 3st at 11:30
Regulating gene expression in 3D during embryonic development